Saignements utérins sous progestatifs implantablesVAN DEN BRULE, Frédéric; GASPARD, Ulysse; FOIDART, Jean-Michel et al.MTE. Médecine thérapeutique endocrinologie. 2004, Vol 6, Num 1, pp 28-34, issn 1295-9359, 7 p.Conference Paper

Pharmacological profile of progestinsSITRUK-WARE, Regine.Maturitas (Amsterdam). 2004, Vol 47, Num 4, pp 277-283, issn 0378-5122, 7 p.Conference Paper

IMMUNOCYTOCHEMICAL LOCALIZATION OF A PROGESTAGEN-ASSOCIATED ENDOMETRIAL PROTEIN IN THE HUMAN DECIDUAMAZURKIEWICZ JE; BANK JF; JOSHI SG et al.1981; J. CLIN. ENDOCRINOL. METAB.; ISSN 0021-972X; USA; DA. 1981; VOL. 52; NO 5; PP. 1006-1008; BIBL. 9 REF.Article

Cancer cachexia: What is known about its etiology and what should be the current treatment approach?VAN HALTEREN, H. K; BONGAERTS, G. P. A; WAGENER, D. J. Th et al.Anticancer research. 2003, Vol 23, Num 6D, pp 5111-5115, issn 0250-7005, 5 p.Article

RADIOIMMUNOASSAY FOR A PROGESTAGEN-ASSOCIATED PROTEIN OF THE HUMAN ENDOMETRIUMJOSHI SG; BANK JF; SZAROWSKI DH et al.1981; J. CLIN. ENDOCRINOL. METAB.; ISSN 0021-972X; USA; DA. 1981; VOL. 52; NO 6; PP. 1185-1192; BIBL. 16 REF.Article

New progestogens: A review of their effects in perimenopausal and postmenopausal womenSITRUK-WARE, Régine.Drugs & aging. 2004, Vol 21, Num 13, pp 865-883, issn 1170-229X, 19 p.Article

Doping in sport-2. Quantification of the impurity 19-norandrostenedione in pharmaceutical preparations of norethisteroneWALKER, Christopher J; COWAN, Dauid A; JAMES, Vivian H. T et al.Steroids. 2009, Vol 74, Num 3, pp 335-340, issn 0039-128X, 6 p.Article

Adequacy of saliva 17-hydroxyprogesterone determination using various collection methodsMYLONAS, Panagiotis G; MAKRI, Maria; GEORGOPOULOS, Neoklis A et al.Steroids. 2006, Vol 71, Num 3, pp 273-276, issn 0039-128X, 4 p.Article

Progestatifs : pharmacologie et propriétés (1^re partie) = Progestagen : pharmacology and proprietiesBERNARD, Laurence; CHRISTIN-MAITRE, Sophie.La Revue du praticien. Gynécologie et obstétrique. 2003, Num 73, pp 17-19, issn 1280-1437, 3 p.Article

Differential Effects of Progestins: European Progestin ClubSCHINDLER, Adolf E.Maturitas (Amsterdam). 2003, Vol 46, issn 0378-5122, 89 p., SUP1Serial Issue

Noncontraceptive estrogens and progestins: use patterns over timeKENNEDY, D. L; BAUM, C; FORBES, M. B et al.Obstetrics and gynecology (New York. 1953). 1985, Vol 65, Num 3, pp 441-446, issn 0029-7844Article

Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndromeLOPEZ, Antonio Pascual; FIGULS, Marta Roqué I; CUCHI, Gerard Urrutia et al.Journal of pain and symptom management. 2004, Vol 27, Num 4, pp 360-369, issn 0885-3924, 10 p.Article

La contraception par les progestatifs normodosés = Contraception using nomodose progestinsPELISSIER-LANGBORT, C.Contraception fertilité sexualité (1973). 1984, Vol 12, Num 10, pp 1099-1109, issn 0301-861XArticle

Immunosuppressive Biological Mechanisms Support Reassessment of Use of the Injectable Contraceptive Medroxyprogesterone AcetateHAPGOOD, Janet P.Endocrinology (Philadelphia). 2013, Vol 154, Num 3, pp 985-988, issn 0013-7227, 4 p.Article

NOTIONS RÉCENTES SUR LES PROGESTATIFSROZENBAUM, Henri.Reproduction humaine et hormones. 2008, Vol 21, Num 5-6, pp 423-429, issn 0994-3919, 7 p.Article

Androgenic action of progestins and possible synandrogenic properties of antiandrogens used in oral contraceptivesSPONA, J.Gynecologic and obstetric investigation. 1984, Vol 17, Num 2, pp 66-72, issn 0378-7346Article

Prospective experience with a levonorgestrel implant. NorplantLOPEZ, G; RODRIGUIZ, A; RENGIFO, J et al.Contraceptive delivery systems. 1984, Vol 5, Num 4, pp 293-302, issn 0143-6112Article

Bilan d'une association estroprogestative contenant un progestatif innovant : quelle évidence ? = Evaluation of a new combined pill containing an innovative gestogen: which evidence?AUDEBERT, Alain.La Revue du praticien. Gynécologie et obstétrique. 2003, Num 77, pp 41-43, issn 1280-1437, 3 p.Article

Selon quelles modalités associer les progestatifs à l'estrogénothérpie de la ménopause pour éviter le cancer endométrial ?ROZENBAUM, H.Concours médical (Paris). 1991, Vol 113, Num 39-40, issn 0010-5309, p. 3515Article

Long-term experience with NORPLANT^® implants in international clinical trialsSIVIN, I; HOLMA, P; DIAZ, S et al.Contraceptive delivery systems. 1984, Vol 5, Num 1, pp 53-62, issn 0143-6112Article

Several Synthetic Progestins with Different Potencies Adversely Affect Reproduction of FishRUNNALLS, Tamsin J; BERESFORD, Nicola; LOSTY, Erin et al.Environmental science & technology. 2013, Vol 47, Num 4, pp 2077-2084, issn 0013-936X, 8 p.Article

Progestogen safety: implications for meta-analysisO'BRIEN, J. M.Ultrasound in obstetrics & gynecology. 2012, Vol 40, Num 4, pp 486-487, issn 0960-7692, 2 p.Article

Progestatifs avant la ménopause : le moment de revenir aux bases ? : Questions et débats en 2008 = Progestagens before menopause : time to get back to basics?THIS, P; PANEL, P.La Lettre du gynécologue. 2008, Num 328-329, pp 17-18, issn 0759-1594, 2 p.Article

Characterization of related impurities in megestrol acetateFUJIANG GUO; HUIJIN FENG; YOUFU WANG et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 4, pp 1418-1422, issn 0731-7085, 5 p.Article

Increased progesterone production during the luteal phase of menstruation may decrease anesthetic requirementERDEN, Veysel; YANGIN, Zehra; ERKALP, Kerem et al.Anesthesia and analgesia. 2005, Vol 101, Num 4, pp 1007-1011, issn 0003-2999, 5 p.Article